STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22

STAT5/OLIG2 对 GBM 治疗耐药和复发的调节 - 重新提交 3.22

基本信息

  • 批准号:
    10583973
  • 负责人:
  • 金额:
    $ 62.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-21 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary Glioblastoma (GBM) is among the most lethal human cancers with extensive genetic and cellular heterogeneity. Genetic heterogeneity in GBM is seen through activation of multiple receptor tyrosine kinases (RTKs) including EGFR. Approximately ~50-60% of GBM tumors harbor amplification of the EGFR gene, including the constitutively active variant EGFRvIII, and point mutations within the extracellular domain of EGFR. Clinical effort at targeting EGFR itself has failed to increase survival, in part due to redundancy in the downstream signaling pathways triggered through EGFR or other oncogenic RTKs. Our data shows that EGFRvIII and possibly the hot spot mutations promote therapeutic resistance through downstream activation of oncogenic STAT5 signaling. Thus, understanding how STAT5 can serve as a point of convergence for oncogenic RTKs, such as EGFR will provide new opportunities for therapeutic interventions in GBM patients. One of the reasons why role of STAT5 signaling has been underappreciated in GBM is because long-term cultured GBM cells often lose EGFRvIII expression and do not show STAT5 activation. However, primary GBMs that retain EGFRvIII expression exhibit active STAT5 signaling. Our data indicate that EGFRvIII signaling activates STAT5 through JAK1/2- independent mechanisms and represents an attractive RTK model for understanding the role of STAT5 in GBM. We also find that therapy-resistant glioma stem cells (GSCs) that retain EGFRvIII expression also have increased STAT5 activation. In GSCs, EGFR participates in a feed-forward loop with a key cell fate and pro-mitogenic transcription factor, OLIG2. GSCs depleted of OLIG2 show decreased levels of phospho- STAT5 and expression of its downstream targets, (e.g. Fn14). Both STAT5 and OLIG2 function as dimers and in GSCs we find that STAT5 interacts with OLIG2. Furthermore, STAT5 inhibition decreases OLIG2- dependent GSC invasion. However, the upstream molecular mechanisms involved in OLIG2-dependent activation of STAT5 and signaling pathway(s) regulated by the OLIG2-STAT5 complex must be identified to effectively target the infiltrative and resistant glioma stem cells. We hypothesize that activation of STAT5-OLIG2 signaling mediated by oncogenic RTKs, such as EGFRvIII, promote increased invasion, therapy resistance, and stemness properties in GBM. Aim 1 will determine the mechanistic role of STAT5 isoform signaling in the context of EGFR variants in GBM cells. Aim 2 will determine the molecular mechanism(s) involved in OLIG2-mediated regulation of STAT5 activation in GSCs. Aim 3 will assess the functional and clinical significance of STAT5-OLIG2 signaling axis in GBM. Success of the proposal will identify, validate, and place into a clinically meaningful context the STAT5/OLIG2 signaling pathway as a therapeutic target for infiltrating cells that commonly underlie GBM fatality.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHWETAL MEHTA其他文献

SHWETAL MEHTA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHWETAL MEHTA', 18)}}的其他基金

Enhancing Treatment Response by Leveraging STAT5-OLIG2 signaling in GBM
利用 GBM 中的 STAT5-OLIG2 信号传导增强治疗反应
  • 批准号:
    10263545
  • 财政年份:
    2020
  • 资助金额:
    $ 62.96万
  • 项目类别:
Downstream Targets of Olig 2
Olig 2 的下游靶标
  • 批准号:
    7488486
  • 财政年份:
    2006
  • 资助金额:
    $ 62.96万
  • 项目类别:
Downstream Targets of Olig 2
Olig 2 的下游靶标
  • 批准号:
    7111895
  • 财政年份:
    2006
  • 资助金额:
    $ 62.96万
  • 项目类别:
Downstream Targets of Olig 2
Olig 2 的下游靶标
  • 批准号:
    7255692
  • 财政年份:
    2006
  • 资助金额:
    $ 62.96万
  • 项目类别:

相似海外基金

Targeting Type I IFN signaling to promote recovery following brain trauma in aged animals
靶向 I 型干扰素信号传导促进老年动物脑外伤后的恢复
  • 批准号:
    10300752
  • 财政年份:
    2022
  • 资助金额:
    $ 62.96万
  • 项目类别:
Targeting Type I IFN signaling to promote recovery following brain trauma in aged animals
靶向 I 型干扰素信号传导促进老年动物脑外伤后的恢复
  • 批准号:
    10618773
  • 财政年份:
    2022
  • 资助金额:
    $ 62.96万
  • 项目类别:
Development of a Frontier Magnetic Resonance (MR) Imaging Technology As a Tool for Visualization and Quantified Vascular-Feature Measurement for Use in Brain and Behavioral Research on Small Animals
开发前沿磁共振 (MR) 成像技术作为可视化和量化血管特征测量的工具,用于小动物的大脑和行为研究
  • 批准号:
    10384839
  • 财政年份:
    2022
  • 资助金额:
    $ 62.96万
  • 项目类别:
The effects of fear on the brain in wild animals
恐惧对野生动物大脑的影响
  • 批准号:
    563879-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 62.96万
  • 项目类别:
    University Undergraduate Student Research Awards
Head-mounted Photoacoustic Imaging of Deep-brain Neural Activities in Freely Behaving Animals
自由行为动物深脑神经活动的头戴式光声成像
  • 批准号:
    9924909
  • 财政年份:
    2020
  • 资助金额:
    $ 62.96万
  • 项目类别:
Probing brain network dynamics in freely behaving animals
探索自由行为动物的大脑网络动态
  • 批准号:
    RTI-2021-00094
  • 财政年份:
    2020
  • 资助金额:
    $ 62.96万
  • 项目类别:
    Research Tools and Instruments
ShEEP Request for Ultrafast Ultrasound for Brain Imaging in Freely Behaving Animals
ShEEP 请求使用超快超声波对自由行为的动物进行脑成像
  • 批准号:
    9908895
  • 财政年份:
    2019
  • 资助金额:
    $ 62.96万
  • 项目类别:
Bio-ultrasound pharmacy: micro-diaphragm development and its application to the brain of awake animals
生物超声药剂学:微隔膜开发及其在清醒动物大脑中的应用
  • 批准号:
    18K19794
  • 财政年份:
    2018
  • 资助金额:
    $ 62.96万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Deciphering brain organisation through optogenetic manipulation in freely moving animals
通过光遗传学操作解读自由活动动物的大脑组织
  • 批准号:
    511913-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 62.96万
  • 项目类别:
    University Undergraduate Student Research Awards
Administrative Supplement: Anion channelrhodopsin-based viral tools to manipulate brain networks in behaving animals
行政补充:基于阴离子通道视紫红质的病毒工具可操纵行为动物的大脑网络
  • 批准号:
    9268890
  • 财政年份:
    2016
  • 资助金额:
    $ 62.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了